Rekah Pharmaceutical Industry Ltd. Stock TEL AVIV STOCK EXCHANGE
Equities
IL0010810096
Pharmaceuticals
Sales 2022 | 292M 77.86M 29.24B 107M | Sales 2023 | 322M 85.65M 32.17B 118M | Capitalization | 169M 44.92M 16.87B 61.64M |
---|---|---|---|---|---|
Net income 2022 | -2M -533K -200M -731K | Net income 2023 | -6M -1.6M -600M -2.19M | EV / Sales 2022 | 1.1 x |
Net Debt 2022 | 145M 38.72M 14.54B 53.13M | Net Debt 2023 | 166M 44.32M 16.64B 60.81M | EV / Sales 2023 | 1.04 x |
P/E ratio 2022 |
-85.5
x | P/E ratio 2023 |
-24.2
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 17.36% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 80 | 93-08-23 | |
Yuval Bernshtein
DFI | Director of Finance/CFO | 44 | 18-10-31 |
Director/Board Member | 78 | 93-08-23 |
Members of the board | Title | Age | Since |
---|---|---|---|
Ishay Davidi
BRD | Director/Board Member | 62 | 15-04-14 |
Amiram Boehm
BRD | Director/Board Member | 52 | 15-04-14 |
Avraham Bigger
CHM | Chairman | 77 | 15-04-14 |
1st Jan change | Capi. | |
---|---|---|
-1.17% | 24.26B | |
+15.06% | 8.74B | |
+1.22% | 8.21B | |
-31.14% | 6.87B | |
+16.30% | 5.29B | |
+2.20% | 4.13B | |
-9.24% | 3.79B | |
-8.91% | 3.34B | |
+7.27% | 3.19B |